Your browser doesn't support javascript.
loading
Nitric Oxide-Releasing Nanoparticles Prevent Propionibacterium acnes-Induced Inflammation by Both Clearing the Organism and Inhibiting Microbial Stimulation of the Innate Immune Response.
Qin, Min; Landriscina, Angelo; Rosen, Jamie M; Wei, Gabrielle; Kao, Stephanie; Olcott, William; Agak, George W; Paz, Karin B; Bonventre, Josephine; Clendaniel, Alicea; Harper, Stacey; Adler, Brandon L; Krausz, Aimee E; Friedman, Joel M; Nosanchuk, Joshua D; Kim, Jenny; Friedman, Adam J.
Afiliación
  • Qin M; Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Landriscina A; Division of Dermatology, Department of Medicine, Montefiore Medical Center, Bronx, New York, USA.
  • Rosen JM; Division of Dermatology, Department of Medicine, Montefiore Medical Center, Bronx, New York, USA.
  • Wei G; Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Kao S; Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Olcott W; Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Agak GW; Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Paz KB; Division of Dermatology, Department of Medicine, Montefiore Medical Center, Bronx, New York, USA.
  • Bonventre J; Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, Oregon, USA.
  • Clendaniel A; Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, Oregon, USA.
  • Harper S; Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, Oregon, USA; School of Chemical, Biological and Environmental Engineering, Oregon State University, Corvallis, Oregon, USA.
  • Adler BL; Division of Dermatology, Department of Medicine, Montefiore Medical Center, Bronx, New York, USA.
  • Krausz AE; Division of Dermatology, Department of Medicine, Montefiore Medical Center, Bronx, New York, USA.
  • Friedman JM; Department of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Nosanchuk JD; Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Kim J; Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA; Department of Dermatology, Greater Los Angeles Healthcare Service Veterans Affairs, Los Angeles, California, USA.
  • Friedman AJ; Division of Dermatology, Department of Medicine, Montefiore Medical Center, Bronx, New York, USA; Department of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, New York, USA; Department of Dermatology, George Washington School of Medicine and Health Sciences, Washington, DC, U
J Invest Dermatol ; 135(11): 2723-2731, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26172313

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Propionibacterium acnes / Interleucina-1 / Inmunidad Innata / Óxido Nítrico Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Invest Dermatol Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Propionibacterium acnes / Interleucina-1 / Inmunidad Innata / Óxido Nítrico Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Invest Dermatol Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos